We are live on ! Find out more
GDRX icon

GoodRx Holdings

174 hedge funds and large institutions have $916M invested in GoodRx Holdings in 2022 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 32

31% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 36

19.36% more ownership

Funds ownership: 167.61%186.97% (+19%)

4% more funds holding

Funds holding: 167174 (+7)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

1% less call options, than puts

Call options by funds: $10.5M | Put options by funds: $10.5M

67% less capital invested

Capital invested by funds: $2.79B → $916M (-$1.88B)

Holders
174
Holders Change
+7
Holders Change %
+4.19%
% of All Funds
2.93%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
47
Increased
58
Reduced
32
Closed
36
Calls
$10.5M
Puts
$10.5M
Net Calls
-$70K
Net Calls Change
-$10.4M
Name Holding Trade Value Shares
Change
Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$3.1M +$5.84M +524,343 New
Alyeska Investment Group
27
Alyeska Investment Group
Illinois
$2.96M
UBS Group
28
UBS Group
Switzerland
$2.9M +$1.6M +143,929 +42%
Citadel Advisors
29
Citadel Advisors
Florida
$2.84M +$4.72M +423,994 +765%
Walleye Capital
30
Walleye Capital
New York
$2.58M +$4.85M +435,494 New
CSS
31
Cubist Systematic Strategies
Connecticut
$2.58M +$1.8M +162,161 +59%
Voloridge Investment Management
32
Voloridge Investment Management
Florida
$2.48M +$4.66M +418,282 New
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.27M +$4.26M +382,918 New
Charles Schwab
34
Charles Schwab
California
$2.03M -$63.6K -5,717 -2%
ACM
35
AlphaCrest Capital Management
New York
$1.88M +$2.58M +231,592 +271%
OQS
36
Occudo Quantitative Strategies
Florida
$1.68M +$3.15M +282,865 New
ECM
37
ExodusPoint Capital Management
New York
$1.58M +$2.63M +236,685 +763%
CS
38
Credit Suisse
Switzerland
$1.49M +$452K +40,622 +19%
Capital Fund Management (CFM)
39
Capital Fund Management (CFM)
France
$1.43M +$2.68M +240,808 New
BA
40
Bridgewater Associates
Connecticut
$1.42M -$26.3K -2,359 -1%
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$1.42M +$1.99M +179,112 +299%
Mirae Asset Global Investments
42
Mirae Asset Global Investments
South Korea
$1.41M +$340K +30,579 +15%
BIG
43
Boothe Investment Group
Delaware
$1.28M +$14.2K +1,280 +0.6%
Squarepoint
44
Squarepoint
New York
$1.28M +$1.97M +177,360 +461%
Amundi
45
Amundi
France
$1.14M +$551K +49,513 +36%
Stifel Financial
46
Stifel Financial
Missouri
$1.07M +$400K +35,963 +25%
Swiss National Bank
47
Swiss National Bank
Switzerland
$1.02M +$1.92M +172,600 New
TAS
48
TIFF Advisory Services
Pennsylvania
$868K +$1.63M +146,551 New
Northern Trust
49
Northern Trust
Illinois
$844K +$248K +22,246 +18%
Canada Pension Plan Investment Board
50
Canada Pension Plan Investment Board
Ontario, Canada
$771K +$1.25M +112,000 +614%

GDRX Hedge Fund Activity: Q2 2022 in Review

174 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2022, worth a combined $916M — down 67% from $2.79B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new GDRX positions and 36 closed out — a net gain of 11 holders — while 58 added to existing stakes and 32 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $31.8M. The largest seller was Dragoneer Investment Group, exiting entirely with an estimated $25.1M sold.

  • 174 institutional investors held GoodRx Holdings (GDRX) as of Q2 2022, up from 167 in Q1 2022.
  • Funds reported $916M of GoodRx Holdings stock for Q2 2022, down 67% quarter-over-quarter.
  • 47 funds opened new GoodRx Holdings positions in Q2 2022 and 36 closed out, a net change of +11 holders.
  • The largest GoodRx Holdings buyer in Q2 2022 was Renaissance Technologies, an estimated $31.8M added.
  • The largest GoodRx Holdings seller in Q2 2022 was Dragoneer Investment Group, an estimated $25.1M sold.

Based on aggregated 13F filings for Q2 2022.